- Home
- TNET vs INVA Comparison
TNET vs INVA Comparison
Compare TNET & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNET | INVA |
|---|---|---|
| Founded | 1988 | 1996 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2000 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TNET | INVA |
|---|---|---|
| Price | $42.84 | $21.94 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $65.80 | $32.80 |
| AVG Volume (30 Days) | 336.0K | ★ 527.8K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.57% | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | 1.90 | ★ 2.22 |
| Revenue | ★ $5,010,000,000.00 | $217,217,000.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | $3.30 | $12.65 |
| P/E Ratio | $21.30 | ★ $9.91 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $33.67 | $16.52 |
| 52 Week High | $86.78 | $25.15 |
Technical Indicators
Market Signals| Indicator | TNET | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 57.78 | 37.44 |
| Support Level | $34.47 | $21.91 |
| Resistance Level | $46.38 | $22.76 |
| Average True Range (ATR) | 2.28 | 0.71 |
| MACD | -0.19 | -0.12 |
| Stochastic Oscillator | 59.76 | 8.60 |
Price Performance
Historical ComparisonAbout TNET TriNet Group Inc.
Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.